Global Longlife Hospital and Research Ltd (GLHRL) fair value: what the stock is really worth
As of Nov 19, 2026: fair value (intrinsic value) of Global Longlife Hospital and Research Ltd stock ₹7.11, price ₹15.14, that is 53.0% below the price, quality 65 out of 100. Rating: strongly overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Global Longlife Hospital and Research Ltd
GLHRL · BSEFar too expensive (fair value 53% below the price) and falling price, but solid company: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
55‑month range ₹9.47 – ₹135.35 · fair‑value band ₹5.33 – ₹8.89 · the ₹15.14 price screens above the ₹7.11 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether Global Longlife Hospital and Research is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Global Longlife Hospital and Research Limited, a multispecialty hospital, provides medical and allied services in India.
Show moreShow less
It offers medical services, such as oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anaesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, GI medicine, gynecology, infectious disease, nephrology, and neurology; and surgical services, including CVTS, joint replacement orthopaedics, spine surgery, general surgery, onco surgery, GI surgery, neurosurgery, ENT, plastic surgery, trauma centre, urology, laparoscopic surgery, gynaecology, dental surgery, and vascular surgery.
The company also provides radiology services consisting of mammography, CT scan, X-ray, ultrasound, endoscopy, and sonography; pathology services, including microbiology, biochemistry, clinical pathology, cyto pathology, haematology, and serology; and other services comprising dialysis, pharmacy, ambulance, dietary, and physiotherapy services.
Global Longlife Hospital and Research Limited was Incorporated in 2012 and is based in Ahmedabad, India.
Stock analysis
Global Longlife Hospital and Research Ltd (GLHRL) currently trades at ₹15.14, while our estimate is ₹7.11, 53% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: ₹5.33 (bear) to ₹8.89 (bull), the price of ₹15.14 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 65/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Global Longlife Hospital and Research Ltd reported revenue of ₹0 in FY2026 versus ₹328M in FY2022. Reported net income was −₹17.2M in FY2026.
Key figures
Market cap ₹159M (≈ $1.7M) Micro · EPS (TTM) ₹−1.64 · Return on equity −6.8% · Return on assets (EBIT) 0.0% (5-year average) · Operating margin −19,094% · Revenue (TTM) ₹52.0K · EPS growth (YoY) +20.4% · Free cash flow −₹45.1M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 3 out of 100 (low confidence).
What moves the price
The share trades about 40% below its 52-week high and 60% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 3% fair-value upside, at −53%, GLHRL screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
GLHRL screens overvalued: fair value 53% below the price. Compare with HCA Healthcare, Inc →
Compare Global Longlife Hospital and Research Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 250 stocks
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on equity by industry
- Quality Score by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Fresenius Medical Care AG FMS | $20.95 | $45.53 | +117% | vs GLHRL |
| DaVita Inc DVA | $161.79 | $218.90 | +35% | vs GLHRL |
| Aier Eye Hospital Group 300015 | ¥9.02 | ¥10.88 | +21% | vs GLHRL |
| HCA Healthcare, Inc HCA | $476.35 | $547.34 | +15% | vs GLHRL |
| Tenet Healthcare Corporation THC | $271.34 | $279.20 | +3% | vs GLHRL |
| The Ensign Group ENSG | $182.98 | $140.09 | −23% | vs GLHRL |
| Encompass Health Corporation EHC | $134.93 | $94.81 | −30% | vs GLHRL |
| Fresenius SE FRE | €51.78 | €34.77 | −33% | vs GLHRL |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 207.90 SAR | 109.45 SAR | −47% | vs GLHRL |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,738 | ₹2,908 | −67% | vs GLHRL |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Global Longlife Hospital and Research Ltd (GLHRL) overvalued or undervalued?
What is the fair value of GLHRL?
What is the quality score of GLHRL?
What is the price target for Global Longlife Hospital and Research Ltd (GLHRL)?
What is the Global Longlife Hospital and Research Ltd stock forecast for 2026?
What is the revenue of Global Longlife Hospital and Research Ltd (GLHRL)?
What is the intrinsic value of Global Longlife Hospital and Research Ltd (GLHRL)?
Is Global Longlife Hospital and Research Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of GLHRL?
How much is Global Longlife Hospital and Research Ltd worth?
What do the bullish and bearish scenarios say about GLHRL?
How solid is the balance sheet of Global Longlife Hospital and Research Ltd (GLHRL)?
How far is GLHRL from its 52-week high?
Which stocks are comparable to Global Longlife Hospital and Research Ltd?
Is Global Longlife Hospital and Research Ltd stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Global Longlife Hospital and Research Ltd (GLHRL)?
What should I pay attention to with Global Longlife Hospital and Research Ltd right now?
Key figures of Global Longlife Hospital and Research Ltd
How large is the market capitalisation of Global Longlife Hospital and Research Ltd (GLHRL)?
What are the earnings per share of Global Longlife Hospital and Research Ltd (GLHRL)?
What is the return on equity of Global Longlife Hospital and Research Ltd (GLHRL)?
What is the EBIT return on assets of Global Longlife Hospital and Research Ltd (GLHRL)?
What is the operating margin of Global Longlife Hospital and Research Ltd (GLHRL)?
How fast are earnings growing at Global Longlife Hospital and Research Ltd (GLHRL)?
How much free cash flow does Global Longlife Hospital and Research Ltd (GLHRL) generate?
How much net debt does Global Longlife Hospital and Research Ltd (GLHRL) carry?
Watch Global Longlife Hospital and Research Ltd in the live analysis
One click puts Global Longlife Hospital and Research Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.